Audiogenic Seizure in Fmr1 Knockout Mice
Discover how Melior’s unique phenotypic screening platforms can uncover the untapped value of your candidate therapeutic
Fragile X patients have a mutation in the Fmr1 gene in which the gene, (FMRP; fragile X mental retardation protein), is not expressed. FMRP is an RNA binding protein that plays a pivotal role in synaptic functioning by translational regulation of dendritic mRNAs.
Fmr1 knockout (KO) mice have an increased susceptibility to audiogenic seizures (Thomas et al., 2011; Veeraragavan et al., 2011; Osterweil et al., 2010). Moreover, Fmr1 KO mice are reported to exhibit deficits in learning and memory tests such as fear conditioning (Zhao et al., 2005; Hayashi et al., 2007; Guo et al., 2012; Gu et al., 2002). Overall, this animal model is considered to be a clinically translatable model of fragile X syndrome.
After evaluating locomotor activity, mice are placed into Audiogenic Seizure test chambers with attached alarms. After acclimating, animal behavior is recorded for a 2 minute alarm challenge, a 1 minute resting period and an additional 2 minute challenge.
In the figure above, mice were scored based on their behavior according to a four point severity score. Animals are considered to have a seizure if the severity score is two or above. R-baclofen significantly reduces the seizure score at 3mg/kg dose and eliminates seizure at 6mg/kg dose. Data are mean ± SEM; **p<0.01, ***p<0.001 compared to vehicle; #p<0.05 R-baclofen dose response (N=15).
References
Thomas AM, Bui N, Graham D, Perkins JR, Yuva-Paylor LA, Paylor R. (2011)
Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome. Behav Brain Res. 223(2):310-21
Veeraragavan S, Graham D, Bui N, Yuva-Paylor LA, Wess J, Paylor R. (2011). Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS). Behav Brain Res. 228(1):1-8.
Osterweil EK, Krueger DD, Reinhold K, Bear MF. (2010). Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. J Neurosci. 30(46):15616-27.
Zhao MG, Toyoda H, Ko SW, Ding HK, Wu LJ, Zhuo M. (2005). Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J Neurosci. 25(32):7385-92.
Gu Y, McIlwain KL, Weeber EJ, Yamagata T, Xu B, Antalffy BA, Reyes C, Yuva-Paylor L, Armstrong D, Zoghbi H, Sweatt JD, Paylor R, Nelson DL. (2002). Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice. J Neurosci. 22(7):2753-63.
Hayashi ML, Rao BS, Seo JS, Choi HS, Dolan BM, Choi SY, Chattarji S, Tonegawa S. (2007). Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci U S A. 104(27):11489-94.
Guo W, Murthy AC, Zhang L, Johnson EB, Schaller EG, Allan AM, Zhao X. (2012). Inhibition of GSK3β improves hippocampus-dependent learning and rescues neurogenesis in a mouse model of fragile X syndrome. Hum Mol Genet. 2012 Feb 1;21(3):681-91.
Interested in running the Audiogenic Seizure in Fmr1 Knockout Mice?
Interested in running the Audiogenic Seizure in Fmr1 Knockout Mice?If you are interested in learning more about the Audiogenic Seizure in Fmr1 Knockout Mice, please contact us to start the conversation today!